• Home
  • Search Results
  • Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture.

Polyanionic carbosilane dendrimers prevent hepatitis C virus infection in cell culture.

Nanomedicine : nanotechnology, biology, and medicine (2016-08-27)
Daniel Sepúlveda-Crespo, José Luis Jiménez, Rafael Gómez, Francisco Javier De La Mata, Pedro L Majano, Ma Ángeles Muñoz-Fernández, Pablo Gastaminza
ABSTRACT

Hepatitis C virus (HCV) infection is a major biomedical problem worldwide. Although new direct antiviral agents (DAAs) have been developed for the treatment of chronic HCV infection, the potential emergence of resistant virus variants and the difficulties to implement their administration worldwide make the development of novel antiviral agents an urgent need. Moreover, no effective vaccine is available against HCV and transmission of the virus still occurs particularly when prophylactic measures are not taken. We used a cell-based system to screen a battery of polyanionic carbosilane dendrimers (PCDs) to identify compounds with antiviral activity against HCV and show that they inhibit effective virus adsorption of major HCV genotypes. Interestingly, one of the PCDs irreversibly destabilized infectious virions. This compound displays additive effect in combination with a clinically relevant DAA, sofosbuvir. Our results support further characterization of these molecules as nanotools for the control of hepatitis C virus spread.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Aspartic acid β-hydroxamate, serine racemase inhibitor